All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer

18h agoen
sciencehealth
Read on clinicaltrials.gov

From the article

Conditions : Colorectal Cancer; Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum Interventions : Drug: Fam-Trastuzumab Deruxtecan-Nxki Sponsors : Memorial Sloan Kettering Cancer Center; AstraZeneca; Eli Lilly and Company; National Institutes of Health (NIH) Not yet recruiting
Continue reading on clinicaltrials.gov

You might also wanna read

Rupam Manna: Early Recognition of T-DXd–Associated ILD Can Save Lives

OncoDaily·1d ago

PICC-2: Toripalimab Plus Celecoxib Improves pCR in dMMR Locally Advanced Colorectal Cancer

OncoDaily·8h ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.